Curadev and Bayer agreement shows switch in gears towards STING antagonists, says GlobalData
Together, the companies will develop new drugs for lung disease, cardiovascular disease and other inflammatory diseases. In 2019,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
curadev
Curadev and Bayer agreement shows switch in gears towards STING antagonists: GlobalData
Globally, there are 42 STING agonists and 8 STING antagonists under development.
Bayer and Curadev sign research collaboration and license agreement to develop novel STING…
The collaboration aims to discover new drug candidates for the treatment of lung diseases, cardiovascular diseases and other…